||1. Ulloa-Montoya, F., C.M. Verfaillie, and W.S. Hu, Culture systems for pluripotent stem cells. Journal of Bioscience and Bioengineering, 2005. 100(1): p. 12-27.|
2. Verfaillie, C., Pluripotent stem cells. Transfusion Clinique Et Biologique, 2009. 16(2): p. 65-69.
4. Reya, T., et al., Stem cells, cancer, and cancer stem cells. Nature, 2001. 414(6859): p. 105-111.
5. Fauza, D., Amniotic fluid and placental stem cells. Best Practice & Research in Clinical Obstetrics & Gynaecology, 2004. 18(6): p. 877-891.
6. Kolambkar, Y.M., et al., Chondrogenic differentiation of amniotic fluid-derived stem cells. Journal of Molecular Histology, 2007. 38(5): p. 405-413.
7. De Coppi, P., et al., Isolation of amniotic stem cell lines with potential for therapy. Nature Biotechnology, 2007. 25(1): p. 100-106.
8. Zheng, Y.-B., et al., Characterization and hepatogenic differentiation of mesenchymal stem cells from human amniotic fluid and human bone marrow: A comparative study. Cell Biology International, 2008. 32(11): p. 1439-1448.
9. Tsai, M.-S., et al., Functional network analysis of the transcriptomes of mesenchymal stem cells derived from amniotic fluid, amniotic membrane, cord blood, and bone marrow. Stem Cells, 2007. 25(10): p. 2511-2523.
10. Kim, J., et al., Human amniotic fluid-derived stem cells have characteristics of multipotent stem cells. Cell Proliferation, 2007. 40(1): p. 75-90.
11. Battula, V.L., et al., Human placenta and bone marrow derived MSC cultured in serum-free, b-FGF-containing medium express cell surface frizzled-9 and SSEA-4 and give rise to multilinelage differentiation. Differentiation, 2007. 75(4): p. 279-291.
12. Tsai, M.S., et al., Clonal amniotic fluid-derived stem cells express characteristics of both mesenchymal and neural stem cells. Biology of Reproduction, 2006. 74(3): p. 545-551.
13. Poloni, A., et al., Characterization and expansion of mesenchymal progenitor cells from first-trimester chorionic villi of human placenta. Cytotherapy, 2008. 10(7): p. 690-697.
14. Gucciardo, L., et al., Fetal mesenchymal stem cells: isolation, properties and potential use in perinatology and regenerative medicine. Bjog-an International Journal of Obstetrics and Gynaecology, 2009. 116(2): p. 166-172.
15. Schöler, H.R., The Potential of Stem Cells: An Inventory, in Nikolaus Knoepffler, Dagmar Schipanski, and Stefan Lorenz Sorgner. 2007, Humanbiotechnology as Social Challenge: Ashgate Publishing. p. 28.
16. Klimanskaya, I., et al., Human embryonic stem cells derived without feeder cells. Lancet, 2005. 365(9471): p. 1636-1641.
17. Yabut, O. and H.S. Bernstein, The promise of human embryonic stem cells in aging-associated diseases. Aging-Us, 2011. 3(5): p. 494-508.
18. Higuchi, A., et al., Biomaterials for the Feeder-Free Culture of Human Embryonic Stem Cells and Induced Pluripotent Stem Cells. Chemical Reviews, 2011. 111(5): p. 3021-3035.
19. Okita, K., T. Ichisaka, and S. Yamanaka, Generation of germline-competent induced pluripotent stem cells. Nature, 2007. 448(7151): p. 313-U1.
20. Takahashi, K. and S. Yamanaka, Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 2006. 126(4): p. 663-676.
21. Yu, J., et al., Induced pluripotent stem cell lines derived from human somatic cells. Science, 2007. 318(5858): p. 1917-1920.
22. Lin, S.-L., et al., Mir-302 reprograms human skin cancer cells into a pluripotent ES-cell-like state. Rna-a Publication of the Rna Society, 2008. 14(10): p. 2115-2124.
23. Zhou, H., et al., Generation of Induced Pluripotent Stem Cells Using Recombinant Proteins (vol 4, pg 381, 2009). Cell Stem Cell, 2009. 4(6): p. 581-581.
24. Higuchi, A., et al., Biomimetic Cell Culture Proteins as Extracellular Matrices for Stem Cell Differentiation. Chemical Reviews, 2012. 112(8): p. 4507-4540.
25. Balajthy, Z., et al., Molecular therapies. 2011.
26. Brighton, C.T. and R.M. Hunt, EARLY HISTOLOGICAL AND ULTRASTRUCTURAL-CHANGES IN MEDULLARY FRACTURE CALLUS. Journal of Bone and Joint Surgery-American Volume, 1991. 73A(6): p. 832-847.
27. Bonfield, T.L. and A.I. Caplan, Adult Mesenchymal Stem Cells: An Innovative Therapeutic for Lung Diseases. Discovery Medicine, 2010. 47: p. 337-345.
28. Chamberlain, G., et al., Concise review: Mesenchymal stem cells: Their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells, 2007. 25(11): p. 2739-2749.
29. Gosden, C.M., Amniotic fluid cell types and culture. British Medical Bulletin, 1983. 39(4): p. 348-354.
30. Hoehn, H. and D. Salk, Morphological and biochemical heterogeneity of amniotic fluid cells in culture, in Methods in Cell Biology, A.L. Samuel and J.D. Gretchen, Editors. 1982. p. 11-34.
31. Tsai, M.S., et al., Isolation of human multipotent mesenchymal stem cells from second-trimester amniotic fluid using a novel two-stage culture protocol. Human Reproduction, 2004. 19(6): p. 1450-1456.
32. Jiang, Y.H., et al., Pluripotency of mesenchymal stem cells derived from adult marrow. Nature, 2002. 418(6893): p. 41-49.
33. Perrone, L., et al., Postnatal weight change is influenced by mother-newborn pair leptin levels. Nutrition Research, 2000. 20(11): p. 1531-1536.
34. Zambotti, F., et al., Monoamine metabolites and related compounds in human amniotic fluid: Assay by gas chromatography and gas chromatography-mass spectrometry. Clinica Chimica Acta 1975. 61(3): p. 247-256.
36. Barry, F.P., et al., The monoclonal antibody SH-2, raised against human mesenchymal stem cells, recognizes an epitope on endoglin (CD105). Biochemical and Biophysical Research Communications, 1999. 265(1): p. 134-139.
37. Barry, F., et al., The SH-3 and SH-4 antibodies recognize distinct epitopes on CD73 from human mesenchymal stem cells. Biochemical and Biophysical Research Communications, 2001. 289(2): p. 519-524.
38. Baksh, D., L. Song, and R.S. Tuan, Adult mesenchymal stem cells: characterization, differentiation, and application in cell and gene therapy. Journal of Cellular and Molecular Medicine, 2004. 8(3): p. 301-316.
39. Ririe, K.M., R.P. Rasmussen, and C.T. Wittwer, Product differentiation by analysis of DNA melting curves during the polymerase chain reaction. Analytical Biochemistry, 1997. 245(2): p. 154-160.
40. Shamblott, M.J., et al., Human embryonic germ cell derivatives express a broad range of developmentally distinct markers and proliferate extensively in vitro. Proceedings of the National Academy of Sciences of the United States of America, 2001. 98(1): p. 113-118.
41. Pittenger, M.F., et al., Multilineage potential of adult human mesenchymal stem cells. Science, 1999. 284(5411): p. 143-147.
42. Zuk, P.A., et al., Human adipose tissue is a source of multipotent stem cells. Molecular Biology of the Cell, 2002. 13(12): p. 4279-4295.
43. Engler, A.J., et al., Matrix elasticity directs stem cell lineage specification. Cell, 2006. 126(4): p. 677-689.
44. Higuchi, A., et al., Physical Cues of Biomaterials Guide Stem Cell Differentiation Fate. Chemical Reviews, 2013. 113(5): p. 3297-3328.
45. Salasznyk, R.M., et al., Adhesion to vitronectin and collagen I promotes osteogenic differentiation of human mesenchymal stem cells. Journal of Biomedicine and Biotechnology, 2004(1): p. 24-34.
46. Hashimoto, J., Y. Kariya, and K. Miyazaki, Regulation of proliferation and chondrogenic differentiation of human mesenchymal stem cells by laminin-5 (laminin-332). Stem Cells, 2006. 24(11): p. 2346-2354.
47. Chastain, S.R., et al., Adhesion of mesenchymal stem cells to polymer scaffolds occurs via distinct ECM ligands and controls their osteogenic differentiation. Journal of Biomedical Materials Research Part A, 2006. 78A(1): p. 73-85.
48. Suzuki, S., et al., Effects of Extracellular Matrix on Differentiation of Human Bone Marrow-Derived Mesenchymal Stem Cells into Smooth Muscle Cell Lineage: Utility for Cardiovascular Tissue Engineering. Cells Tissues Organs, 2010. 191(4): p. 269-280.
49. van Dijk, A., et al., Differentiation of human adipose-derived stem cells towards cardiomyocytes is facilitated by laminin. Cell and Tissue Research, 2008. 334(3): p. 457-467.
50. Mruthyunjaya, S., et al., Laminin-1 induces neurite outgrowth in human mesenchymal stem cells in serum/differentiation factors-free conditions through activation of FAK-MEK/ERK signaling pathways. Biochemical and Biophysical Research Communications, 2010. 391(1): p. 43-48.
51. Delcroix, G.J.R., et al., The therapeutic potential of human multipotent mesenchymal stromal cells combined with pharmacologically active microcarriers transplanted in hemi-parkinsonian rats. Biomaterials, 2011. 32(6): p. 1560-1573.
52. Levenberg, S., et al., Differentiation of human embryonic stem cells on three-dimensional polymer scaffolds. Proceedings of the National Academy of Sciences of the United States of America, 2003. 100(22): p. 12741-12746.
53. Park, I.-S., et al., The correlation between human adipose-derived stem cells differentiation and cell adhesion mechanism. Biomaterials, 2009. 30(36): p. 6835-6843.
54. Kubista, M., et al., Brca1 regulates in vitro differentiation of mammary epithelial cells. Oncogene, 2002. 21(31): p. 4747-4756.
55. Soucek, T., et al., A role of the tuberous sclerosis gene-2 product during neuronal differentiation. Oncogene, 1998. 16(17): p. 2197-2204.
56. Prusa, A.R., et al., Neurogenic cells in human amniotic fluid. American Journal of Obstetrics and Gynecology, 2004. 191(1): p. 309-314.
57. Ter Brugge, P.J. and J.A. Jansen, In vitro osteogenic differentiation of rat bone marrow cells subcultured with and without dexamethasone. Tissue Engineering, 2002. 8(2): p. 321-331.
58. Park, J.S., et al., The effect of matrix stiffness on the differentiation of mesenchymal stem cells in response to TGF-beta. Biomaterials, 2011. 32(16): p. 3921-3930.
59. Bhandari, D.R., et al., The simplest method for in vitro beta-cell production from human adult stem cells. Differentiation, 2011. 82(3): p. 144-152.
60. Xie, Q.-P., et al., Human bone marrow mesenchymal stem cells differentiate into insulin-producing cells upon microenvironmental manipulation in vitro. Differentiation, 2009. 77(5): p. 483-491.
61. Gabr, M.M., et al., Generation of Insulin-Producing Cells from Human Bone Marrow-Derived Mesenchymal Stem Cells: Comparison of Three Differentiation Protocols. Biomed Research International, 2014.
62. Czubak, P., et al., A Modified Method of Insulin Producing Cells′ Generation from Bone Marrow-Derived Mesenchymal Stem Cells. Journal of Diabetes Research, 2014.
63. Cooper, G.M., The Cell: A Molecular Approach. 2000-2013.
64. Gilbert, P.M., et al., Substrate Elasticity Regulates Skeletal Muscle Stem Cell Self-Renewal in Culture. Science, 2010. 329(5995): p. 1078-1081.
65. Georges, P.C., et al., Matrices with compliance comparable to that of brain tissue select neuronal over glial growth in mixed cortical cultures. Biophysical Journal, 2006. 90(8): p. 3012-3018.
66. Flanagan, L.A., et al., Neurite branching on deformable substrates. Neuroreport, 2002. 13(18): p. 2411-2415.
67. Hofstetter, C.P., et al., Marrow stromal cells form guiding strands in the injured spinal cord and promote recovery. Proceedings of the National Academy of Sciences of the United States of America, 2002. 99(4): p. 2199-2204.
68. Kondo, T., et al., Sonic hedgehog and retinoic acid synergistically promote sensory fate specification from bone marrow-derived pluripotent stem cells. Proceedings of the National Academy of Sciences of the United States of America, 2005. 102(13): p. 4789-4794.
69. Engler, A.J., et al., Myotubes differentiate optimally on substrates with tissue-like stiffness: pathological implications for soft or stiff microenvironments. Journal of Cell Biology, 2004. 166(6): p. 877-887.
70. Ferrari, G., et al., Muscle regeneration by bone marrow derived myogenic progenitors. Science, 1998. 279(5356): p. 1528-1530.
71. Andrades, J.A., et al., Selection and amplification of a bone marrow cell population and its induction to the chondro-osteogenic lineage by rhOP-1: an in vitro and in vivo study. International Journal of Developmental Biology, 2001. 45(4): p. 689-693.
72. Holmbeck, K., et al., MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover. Cell, 1999. 99(1): p. 81-92.
73. Morinobu, M., et al., Osteopontin expression in osteoblasts and osteocytes during bone formation under mechanical stress in the calvarial suture in vivo. Journal of Bone and Mineral Research, 2003. 18(9): p. 1706-1715.
74. Deng, J., et al., Mesenchymal stem cells spontaneously express neural proteins in culture and are neurogenic after transplantation. Stem Cells, 2006. 24(4): p. 1054-1064.
75. McBeath, R., et al., Cell shape, cytoskeletal tension, and RhoA regulate stem cell lineage commitment. Developmental Cell, 2004. 6(4): p. 483-495.
76. LaIuppa, J.A., et al., Culture materials affect ex vivo expansion of hematopoietic progenitor cells. Journal of Biomedical Materials Research, 1997. 36(3): p. 347-359.
77. Seraj, M.J., et al., Functional evidence for a novel human breast carcinoma metastasis suppressor, BRMS1, encoded at chromosome 11q13. Cancer Research, 2000. 60(11): p. 2764-2769.
78. Discher, D.E., P. Janmey, and Y.L. Wang, Tissue cells feel and respond to the stiffness of their substrate. Science, 2005. 310(5751): p. 1139-1143.
79. Pelham, R.J. and Y.L. Wang, Cell locomotion and focal adhesions are regulated by substrate flexibility. Proceedings of the National Academy of Sciences of the United States of America, 1997. 94(25): p. 13661-13665.
80. Engler, A., et al., Substrate compliance versus ligand density in cell on gel responses. Biophysical Journal, 2004. 86(1): p. 617-628.
81. Georges, P.C. and P.A. Janmey, Cell type-specific response to growth on soft materials. Journal of Applied Physiology, 2005. 98(4): p. 1547-1553.
82. Lu, Z., et al., Collagen Type II Enhances Chondrogenesis in Adipose Tissue-Derived Stem Cells by Affecting Cell Shape. Tissue Engineering Part A, 2010. 16(1): p. 81-90.
83. Kikkawa, Y., et al., Integrin binding specificity of laminin-10/11 : laminin-10/11 are recognized by alpha 3 beta 1, alpha 6 beta 1 and alpha 6 beta 4 integrins. Journal of Cell Science, 2000. 113(5): p. 869-876.
84. Jiang, X.S., et al., Surface-immobilization of adhesion peptides on substrate for ex vivo expansion of cryopreserved umbilical cord blood CD34(+) cells. Biomaterials, 2006. 27(13): p. 2723-2732.
85. Gelain, F., et al., Designer Self-Assembling Peptide Nanofiber Scaffolds for Adult Mouse Neural Stem Cell 3-Dimensional Cultures. Plos One, 2006. 1(2).
86. Frontiers in tissue engineering. 1998.
87. Rosso, F., et al., From cell-ECM interactions to tissue engineering. Journal of Cellular Physiology, 2004. 199(2): p. 174-180.
88. Langer, R. and J.P. Vacanti, Tissue engineering. Science, 1993. 260(5110): p. 920-926.
89. Barbucci, R., Integrated Biomaterials Science. 2002.
90. Putnam, A.J. and D.J. Mooney, Tissue engineering using synthetic extracellular matrices. Nature Medicine, 1996. 2(7): p. 824-826.
91. Daley, W.P., S.B. Peters, and M. Larsen, Extracellular matrix dynamics in development and regenerative medicine. Journal of Cell Science, 2008. 121(3): p. 255-264.
92. Rozario, T. and D.W. DeSimone, The extracellular matrix in development and morphogenesis: A dynamic view. Developmental Biology, 2010. 341(1): p. 126-140.
93. Chen, L.-Y., et al., Effect of the surface density of nanosegments immobilized on culture dishes on ex vivo expansion of hematopoietic stem and progenitor cells from umbilical cord blood. Acta Biomaterialia, 2012. 8(5): p. 1749-1758.
94. Koivunen, E., B.C. Wang, and E. Ruoslahti, Phage Libraries Displaying Cyclic Peptides with Different Ring Sizes: Ligand Specificities of the RGD-Directed Integrins. Bio-Technology, 1995. 13(3): p. 265-270.
95. Kolhar, P., et al., Synthetic surfaces for human embryonic stem cell culture. Journal of Biotechnology, 2010. 146(3): p. 143-146.
96. Klim, J.R., et al., A defined glycosaminoglycan-binding substratum for human pluripotent stem cells. Nature Methods, 2010. 7(12): p. 989-994.
97. Rosso, F., et al., Smart materials as scaffolds for tissue engineering. Journal of Cellular Physiology, 2005. 203(3): p. 465-470.
98. Moroni, L., J.R. De Wijn, and C.A. Van Blitterswijk, Integrating novel technologies to fabricate smart scaffolds. Journal of Biomaterials Science-Polymer Edition, 2008. 19(5): p. 543-572.
99. Mano, J.F., et al., Natural origin biodegradable systems in tissue engineering and regenerative medicine: present status and some moving trends. Journal of the Royal Society Interface, 2007. 4(17): p. 999-1030.
100. Lee, C.H., A. Singla, and Y. Lee, Biomedical applications of collagen. International Journal of Pharmaceutics, 2001. 221(1-2): p. 1-22.
101. Pankov, R. and K.M. Yamada, Fibronectin at a glance. Journal of Cell Science, 2002. 115(20): p. 3861-3863.
102. Mao, Y. and J.E. Schwarzbauer, Fibronectin fibrillogenesis, a cell-mediated matrix assembly process. Matrix Biology, 2005. 24(6): p. 389-399.
104. Ogawa, T., et al., The short arm of laminin gamma 2 chain of laminin-5 (laminin-332) binds syndecan-1 and regulates cellular adhesion and migration by suppressing phosphorylation of integrin beta 4 chain. Molecular Biology of the Cell, 2007. 18(5): p. 1621-1633.
105. Klees, R.F., et al., Laminin-5 induces osteogenic gene expression in human mesenchymal stem cells through an ERK-dependent pathway. Molecular Biology of the Cell, 2005. 16(2): p. 881-890.
106. Ma, W., et al., Cell-extracellular matrix interactions regulate neural differentiation of human embryonic stem cells. Bmc Developmental Biology, 2008. 8.
107. Tate, C.C., et al., Laminin and fibronectin scaffolds enhance neural stem cell transplantation into the injured brain. Journal of Tissue Engineering and Regenerative Medicine, 2009. 3(3): p. 208-217.
108. Hayman, M.W., et al., Growth of human stem cell-derived neurons on solid three-dimensional polymers. Journal of Biochemical and Biophysical Methods, 2005. 62(3): p. 231-240.
109. Martinez-Ramos, C., et al., Differentiation of postnatal neural stem cells into glia and functional neurons on laminin-coated polymeric substrates. Tissue Engineering Part A, 2008. 14(8): p. 1365-1375.
110. Li, S., et al., Matrix assembly, regulation, and survival functions of laminin and its receptors in embryonic stem cell differentiation. Journal of Cell Biology, 2002. 157(7): p. 1279-1290.
111. Hall, P.E., et al., Laminin enhances the growth of human neural stem cells in defined culture media. Bmc Neuroscience, 2008. 9.
112. Delcroix, G.J.R., et al., Adult cell therapy for brain neuronal damages and the role of tissue engineering. Biomaterials, 2010. 31(8): p. 2105-2120.
113. Kleinman, H.K. and G.R. Martin, Matrigel: Basement membrane matrix with biological activity. Seminars in Cancer Biology, 2005. 15(5): p. 378-386.
114. Haque, A., et al., The effect of recombinant E-cadherin substratum on the differentiation of endoderm-derived hepatocyte-like cells from embryonic stem cells. Biomaterials, 2011. 32(8): p. 2032-2042.
115. Kaur, G., et al., The promotion of osteoblastic differentiation of rat bone marrow stromal cells by a polyvalent plant mosaic virus. Biomaterials, 2008. 29(30): p. 4074-4081.
116. Yue, X.-S., et al., A fusion protein N-cadherin-Fc as an artificial extracellular matrix surface for maintenance of stem cell features. Biomaterials, 2010. 31(20): p. 5287-5296.
117. Shi, C., et al., Stem-cell-capturing collagen scaffold promotes cardiac tissue regeneration. Biomaterials, 2011. 32(10): p. 2508-2515.
118. Lee, H.J., et al., Enhanced Chondrogenesis of Mesenchymal Stem Cells in Collagen Mimetic Peptide-Mediated Microenvironment. Tissue Engineering Part A, 2008. 14(11): p. 1843-1851.
119. You, M., et al., Chondrogenic differentiation of human bone marrow mesenchymal stem cells on polyhydroxyalkanoate (PHA) scaffolds coated with PHA granule binding protein PhaP fused with RGD peptide. Biomaterials, 2011. 32(9): p. 2305-2313.
120. Hennessy, K.M., et al., The effect of collagen I mimetic peptides on mesenchymal stem cell adhesion and differentiation, and on bone formation at hydroxyapatite surfaces. Biomaterials, 2009. 30(10): p. 1898-1909.
121. Yang, F., et al., The effect of incorporating RGD adhesive peptide in polyethylene glycol diacrylate hydrogel on osteogenesis of bone marrow stromal cells. Biomaterials, 2005. 26(30): p. 5991-5998.
122. Nguyen, L.H., et al., Unique biomaterial compositions direct bone marrow stem cells into specific chondrocytic phenotypes corresponding to the various zones of articular cartilage. Biomaterials, 2011. 32(5): p. 1327-1338.
123. Betre, H., et al., Chondrocytic differentiation of human adipose-derived adult stem cells in elastin-like polypeptide. Biomaterials, 2006. 27(1): p. 91-99.
124. Meinel, L., et al., Engineering bone-like tissue in vitro using human bone marrow stem cells and silk scaffolds. Journal of Biomedical Materials Research Part A, 2004. 71A(1): p. 25-34.
125. Santiago, L.Y., et al., Peptide-surface modification of poly(caprolactone) with laminin-derived sequences for adipose-derived stem cell applications. Biomaterials, 2006. 27(15): p. 2962-2969.
126. Wojtowicz, A.M., et al., Coating of biomaterial scaffolds with the collagen-mimetic peptide GFOGER for bone defect repair. Biomaterials, 2010. 31(9): p. 2574-2582.
127. Cooke, M.J., et al., Neural differentiation regulated by biomimetic surfaces presenting motifs of extracellular matrix proteins. Journal of Biomedical Materials Research Part A, 2010. 93A(3): p. 824-832.
128. Anderson, J.M., et al., Osteogenic Differentiation of Human Mesenchymal Stem Cells Directed by Extracellular Matrix-Mimicking Ligands in a Biomimetic Self-Assembled Peptide Amphiphile Nanomatrix. Biomacromolecules, 2009. 10(10): p. 2935-2944.
129. Bhatnagar, R.S., J.J. Qian, and C.A. Gough, The role in cell binding of a beta-bend within the triple helical region in collagen alpha 1(I) chain: Structural and biological evidence for conformational tautomerism on fiber surface. Journal of Biomolecular Structure & Dynamics, 1997. 14(5): p. 547-60.
130. Higuchi, A., et al., Polymeric Materials for Ex vivo Expansion of Hematopoietic Progenitor and Stem Cells. Polymer Reviews, 2009. 49(3): p. 181-200.
131. Melkoumian, Z., et al., Synthetic peptide-acrylate surfaces for long-term self-renewal and cardiomyocyte differentiation of human embryonic stem cells. Nature Biotechnology, 2010. 28(6): p. 606-610.
132. Pierschbacher, M.D. and E. Ruoslahti, Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule. Nature, 1984. 309(5963): p. 30-33.
133. Suzuki, S., et al., Complete amino acid sequence of human vitronectin deduced from cDNA. Similarity of cell attachment sites in vitronectin and fibronectin. The Embo Journal, 1985. 4(10): p. 2519-2524.
134. Oldberg, A., A. Franzén, and D. Heinegård, The primary structure of a cell-binding bone sialoprotein. The Journal of Biological Chemistry, 1988. 263(36): p. 19430-19432.
135. Scadden, D.T., The stem-cell niche as an entity of action. Nature, 2006. 441(7097): p. 1075-1079.
136. Nilsson, S.K., et al., Osteopontin, a key component of the hematopoietic stem cell niche and regulator of primitive hematopoietic progenitor cells. Blood, 2005. 106(4): p. 1232-1239.
137. Moore, K.A. and I.R. Lemischka, Stem cells and their niches. Science, 2006. 311(5769): p. 1880-1885.
138. Schofield, R., The relationship between the spleen colony-forming cell and the haemopoietic stem cell. Blood Cells, 1978. 4(1-2): p. 7-25.
139. Li, L.H. and T. Xie, Stem cell niche: Structure and function, in Annual Review of Cell and Developmental Biology. 2005. p. 605-631.
140. Jensen, U.B., S. Lowell, and F.M. Watt, The spatial relationship between stem cells and their progeny in the basal layer of human epidermis: a new view based on whole-mount labelling and lineage analysis. Development, 1999. 126(11): p. 2409-2418.
141. Nuttelman, C.R., M.C. Tripodi, and K.S. Anseth, Synthetic hydrogel niches that promote hMSC viability. Matrix Biology, 2005. 24(3): p. 208-218.
142. Feng, Q., et al., Expansion of engrafting human hematopoietic stem/progenitor cells in three-dimensional scaffolds with surface-immobilized fibronectin. Journal of Biomedical Materials Research Part A, 2006. 78A(4): p. 781-791.
143. Gerecht, S., et al., Hyaluronic acid hydrogen for controlled self-renewal and differentiation of human embryonic stem cells. Proceedings of the National Academy of Sciences of the United States of America, 2007. 104(27): p. 11298-11303.
144. Chang, C.-F., et al., Three-dimensional collagen fiber remodeling by mesenchymal stem cells requires the integrin-matrix interaction. Journal of Biomedical Materials Research Part A, 2007. 80A(2): p. 466-474.
145. Donovan, P.J. and J. Gearhart, The end of the beginning for pluripotent stem cells. Nature, 2001. 414(6859): p. 92-97.
146. Rosner, M.H., et al., A POU-domain transcription factor in early stem cells and germ cells of the mammalian embryo. Nature, 1990. 345(6277): p. 686-692.
147. Scholer, H.R., et al., Oct-4: a germline-specific transcription factor mapping to the mouse t-complex. Embo Journal, 1990. 9(7): p. 2185-2195.
148. Scholer, H.R., et al., New type of POU domain in germ line-specific protein Oct-4. Nature, 1990. 344(6265): p. 435-439.
149. Avilion, A.A., et al., Multipotent cell lineages in early mouse development depend on SOX2 function. Genes & Development, 2003. 17(1): p. 126-140.
150. Chambers, I., et al., Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell, 2003. 113(5): p. 643-655.
151. Mitsui, K., et al., The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell, 2003. 113(5): p. 631-642.
152. Carlin, R., et al., Expression of early transcription factors Oct-4, Sox-2 and Nanog by porcine umbilical cord (PUC) matrix cells. Reproductive Biology and Endocrinology, 2006. 4.
153. Darr, H., Y. Mayshar, and N. Benvenisty, Overexpression of NANOG in human ES cells enables feeder-free growth while inducing primitive ectoderm features. Development, 2006. 133(6): p. 1193-1201.
154. Zaehres, H., et al., High-efficiency RNA interference in human embryonic stem cells. Stem Cells, 2005. 23(3): p. 299-305.
155. Chambers, I. and S.R. Tomlinson, The transcriptional foundation of pluripotency. Development, 2009. 136(14): p. 2311-2322.
156. Masui, S., et al., Pluripotency governed by Sox2 via regulation of Oct3/4 expression in mouse embryonic stem cells. Nature Cell Biology, 2007. 9(6): p. 625-U26.
157. Takeda, J., S. Seino, and G.I. Bell, Human Oct3 gene family: cDNA sequences, alternative splicing, gene organization, chromosomal location, and expression at low levels in adult tissues. Nucleic Acids Research, 1992. 20(17): p. 4613-4620.
158. Boyer, L.A., et al., Core transcriptional regulatory circuitry in human embryonic stem cells. Cell, 2005. 122(6): p. 947-956.
159. Looijenga, L.H.J., et al., POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors. Cancer Research, 2003. 63(9): p. 2244-2250.
160. Rodda, D.J., et al., Transcriptional regulation of Nanog by Oct4 and Sox2. Journal of Biological Chemistry, 2005. 280(26): p. 24731-24737.
161. Otto, F., et al., Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell, 1997. 89(5): p. 765-771.
162. Komori, T., Regulation of osteoblast differentiation by transcription factors. Journal of Cellular Biochemistry, 2006. 99(5): p. 1233-1239.
163. Otto, F., H. Kanegane, and S. Mundlos, Mutations in the RUNX2 gene in patients with clelidocranial dysplasia. Human Mutation, 2002. 19(3): p. 209-216.
164. Aubin, J.E., et al., Intermediate filaments of the vimentin-type and the cytokeratin-type are distributed differently during mitosis. Experimental Cell Research, 1980. 129(1): p. 149-165.
165. Chou, Y.H., et al., Intermediate Filament Reorganization during Mitosis Is Mediated by P34cdc2 Phosphorylation of Vimentin. Cell, 1990. 62(6): p. 1063-1071.
166. Chou, Y.H., et al., The relative roles of specific N- and C-terminal phosphorylation sites in the disassembly of intermediate filament in mitotic BHK-21 cells. Journal of Cell Science, 1996. 109: p. 817-826.
167. Chou, Y.H., et al., Nestin promotes the phosphorylation-dependent disassembly of vimentin intermediate filaments during mitosis. Molecular Biology of the Cell, 2003. 14(4): p. 1468-1478.
168. Eliasson, C., et al., Intermediate filament protein partnership in astrocytes. Journal of Biological Chemistry, 1999. 274(34): p. 23996-24006.
169. Kachinsky, A.M., J.A. Dominov, and J.B. Miller, Intermediate filaments in cardiac myogenesis: nestin in the developing mouse heart. Journal of Histochemistry & Cytochemistry, 1995. 43(8): p. 843-847.
170. Michalczyk, K. and M. Ziman, Nestin structure and predicted function in cellular cytoskeletal organisation. Histology and Histopathology, 2005. 20(2): p. 665-671.
171. Seguin, C.A., et al., Establishment of endoderm progenitors by SOX transcription factor expression in human embryonic stem cells. Cell Stem Cell, 2008. 3(2): p. 182-195.
172. O′Connor, J., B. Sexton, and R.S.C. Smart, Surface analysis methods in materials science. Springer-Verlag.
173. Chadwick, K., et al., Cytokines and BMP-4 promote hematopoietic differentiation of human embryonic stem cells. Blood, 2003. 102(3): p. 906-915.
174. Chien, A., D.B. Edgar, and J.M. Trela, Deoxyribonucleic acid polymerase from the extreme thermophile Thermus aquaticus. J Bacteriol, 1976. 127(3): p. 1550-1557.
175. Freeman, W.M., S.J. Walker, and K.E. Vrana, Quantitative RT-PCR: Pitfalls and potential. Biotechniques, 1999. 26(1): p. 112-+.
176. Lawyer, F.C., et al., High-level expression, purification, and enzymatic characterization of full-length Thermus aquaticus DNA polymerase and a truncated form deficient in 5′ to 3′ exonuclease activity. PCR Methods Appl, 1993. 2(4): p. 275-287.
177. Simmons, P.J. and B. Torokstorb, Identification of stromal cell precursors in human bone marrow by a novel monoclonal antibody, STRO-1. Blood, 1991. 78(1): p. 55-62.
178. Gilliland, G., et al., Analysis of cytokine mRNA and DNA: detection and quantitation by competitive polymerase chain reaction. Proceedings of the National Academy of Sciences of the United States of America, 1990. 87(7): p. 2725-2729.
179. Rappolee, D.A., et al., Wound macrophages express TGF-alpha and other growth factors in vivo: analysis by mRNA phenotyping. Science, 1988. 241(4866): p. 708-712.
180. Becker-André, M. and K. Hahlbrock, Absolute mRNA quantification using the polymerase chain reaction (PCR). A novel approach by a PCR aided transcript titration assay (PATTY). Nucleic Acids Research, 1989. 17(22): p. 9437-9446.
181. Zhang, S.C., et al., In vitro differentiation of transplantable neural precursors from human embryonic stem cells. Nature Biotechnology, 2001. 19(12): p. 1129-1133.
182. Cheng, S., et al., Effective amplification of long targets from cloned inserts and human genomic DNA. Proceedings of the National Academy of Sciences of the United States of America, 1994. 91(12): p. 5695-5699.
183. Holland, P.M., et al., Detection of Specific Polymerase Chain-Reaction Product by Utilizing the 5′-]3′ Exonuclease Activity of Thermus-Aquaticus DNA-Polymerase. Proceedings of the National Academy of Sciences of the United States of America, 1991. 88(16): p. 7276-7280.
184. Chen, C.F., et al., Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Research, 2005. 33(20).
185. Niesters, H.G.M., Quantitation of viral load using real-time amplification techniques. Methods, 2001. 25(4): p. 419-429.
186. Livak, K.J. and T.D. Schmittgen, Analysis of relative gene expression data using real-time quantitative PCR and the 2(T)(-Delta Delta C) method. Methods, 2001. 25(4): p. 402-408.
187. Schmittgen, T.D. and K.J. Livak, Analyzing real-time PCR data by the comparative C-T method. Nature Protocols, 2008. 3(6): p. 1101-1108.